Transport activity of human MRP3 expressed in Sf9 cells: Comparative studies with rat MRP3

被引:113
|
作者
Akita, H
Suzuki, H [1 ]
Hirohashi, T
Takikawa, H
Sugiyama, Y
机构
[1] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan
[2] Teikyo Univ, Sch Med, Dept Med, Itabashi Ku, Tokyo 1730003, Japan
关键词
ABC transporter; bile acids; MRP3; organic anion;
D O I
10.1023/A:1013699130991
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. Multidrug resistance-associated protein 3 (MRP3) was initially cloned as a hepatic transporter induced under cholestatic/hyperbilirubinemic conditions. In the present study, transport property of human MRP3 (hMRP3) was compared with that of rat MRP3 (rMRP3). Methods. Adenosine 5' triphosphate (ATP)-dependent uptake of several organic anions into the membrane vesicles isolated from the Sf9 cells expressing hMRP3 and rMRP3 was measured by rapid filtration technique. Results. ATP-dependent uptake of glucuronide conjugates, glutathione conjugates, and [H-3]methotrexate (MTX) was stimulated by infection of cDNAs for hMRP3 and rMRP3. The mean (+/- SE) K-m values for the uptake of 17beta estradiol 17beta-D-glucuronide ([H-3]E(2)17 betaG) by hMRP3 and rMRP3 were 42.9 +/- 4.3 muM and 33.4 +/- 2.2 mum, respectively. Although the K-i values of glucuronides on the uptake of E(2)17betaG were similar in humans and rats, hMRP3 exhibited higher K-i values toward MTX. In addition. although glycocholate and taurolithocholate 3-sulfate (TLC-S) were transported by both hMRP3 and rMRP3, taurocholate was only transported to a significant degree by rMRP3. Moreover, the inhibitory effect of taurocholate and glycocholate on the transport of E(2)17betaG was much more potent in rMRP3 compared to hMRP3. Conclusion. Collectively, the substrate specificity of hMRP3 resembles that of rMRP3 although differences were observed, particularly in bile acid transport.
引用
收藏
页码:34 / 41
页数:8
相关论文
共 50 条
  • [1] Transport Activity of Human MRP3 Expressed in Sf9 Cells: Comparative Studies with Rat MRP3
    Hidetaka Akita
    Hiroshi Suzuki
    Tomoko Hirohashi
    Hajime Takikawa
    Yuichi Sugiyama
    Pharmaceutical Research, 2002, 19 : 34 - 41
  • [2] Ethynylestradiol increases expression and activity of rat liver MRP3
    Ruiz, Maria L.
    Villanueva, Silvina S. M.
    Luquita, Marcelo G.
    Vore, Mary
    Mottino, Aldo D.
    Catania, Viviana A.
    DRUG METABOLISM AND DISPOSITION, 2006, 34 (06) : 1030 - 1034
  • [3] Identification of novel inhibitors of rat Mrp3
    De Vocht, Tom
    Buyck, Christophe
    Deferm, Neel
    Qi, Bing
    Van Brantegem, Pieter
    van Vlijmen, Herman
    Snoeys, Jan
    Hoeben, Eef
    Vermeulen, An
    Annaert, Pieter
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2021, 162
  • [4] Interaction of hesperetin glucuronide conjugates with human BCRP, MRP2 and MRP3 as detected in membrane vesicles of overexpressing baculovirus-infected Sf9 cells
    Brand, Walter
    Oosterhuis, Berend
    Krajcsi, Peter
    Barron, Denis
    Dionisi, Fabiola
    van Bladeren, Peter J.
    Rietjens, Ivonne M. C. M.
    Williamson, Gary
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2011, 32 (09) : 530 - 535
  • [5] Transcriptional regulation of the rat Mrp3 promoter in intestine cells
    Tzeng, SJ
    Huang, JD
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 291 (02) : 270 - 277
  • [6] Efflux transport of estrogen glucuronides by human MRP2, MRP3, MRP4 and BCRP
    Jarvinen, Erkka
    Deng, Feng
    Kidron, Heidi
    Finel, Moshe
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2018, 178 : 99 - 107
  • [7] Characterization of inducible nature of MRP3 in rat liver
    Ogawa, K
    Suzuki, H
    Hirohashi, T
    Ishikawa, T
    Meier, PJ
    Hirose, K
    Akizawa, T
    Yoshioka, M
    Sugiyama, Y
    AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2000, 278 (03): : G438 - G446
  • [8] Analysis of the in vivo functions of Mrp3
    Belinsky, MG
    Dawson, PA
    Shchaveleva, I
    Bain, LJ
    Wang, RX
    Ling, V
    Chen, ZS
    Grinberg, A
    Westphal, H
    Klein-Szanto, A
    Lerro, A
    Kruh, GD
    MOLECULAR PHARMACOLOGY, 2005, 68 (01) : 160 - 168
  • [9] Characterization of 5′-flanking region of human MRP3
    Takada, T
    Suzuki, H
    Sugiyama, Y
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 270 (03) : 728 - 732
  • [10] Differential regulation of the human MRP2 and MRP3 gene expression by glucocorticoids
    Pulaski, L
    Kania, K
    Ratajewski, M
    Uchiumi, T
    Kuwano, M
    Bartosz, G
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2005, 96 (3-4): : 229 - 234